Connie L. Erickson‐Miller
South College(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Glycosylation and Glycoproteins Research, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, Lipid metabolism and disorders
Most-Cited Works
- → Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist(2007)299 cited
- → Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia(2010)296 cited
- → Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist(2008)282 cited
- → Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist(2005)204 cited
- → Endothelial HIF-2 mediates protection and recovery from ischemic kidney injury(2014)191 cited
- → Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils(2000)160 cited
- →